Blood products, namely, plasma volume expanders, blood plasma, human albumin, blood clotting factors and immunoglobulins for medical and clinical use; pharmaceutical preparations derived from plasma and recombinant DNA technology for the prevention and/or treatment of blood disorders; products derived from recombinant DNA technology, namely, plasma volume expanders; human albumin, blood clotting factors and immunoglobulins for medical or clinical use

Printed matter and publications, namely, books, magazines, newsletters, brochures, leaflets and periodicals all featuring material in relation to pharmaceutical products, blood, blood products, bleeding disorders and blood fractionation; printed educational and teaching material in the field of pharmaceutical products, blood, blood products, bleeding disorders and blood fractionation; stationery; calendars and posters

Treatment of human biological products, namely, custom manufacturing and fractionation of blood, and transformation of blood products and products derived from blood and/or recombinant DNA technology